Drug Trial Radar · NCT03249337
Glanatec(R) for Descemet Stripping in Fuch's Endothelial Dystrophy
Last checked: Nov 19, 2026Latest source record: Aug 11, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
30
Planned (sponsor's estimate)
Start
Dec 6, 2017
Primary completion
Dec 2021
Study completion Dec 2021
Sponsor
- Lead sponsor
- Marian Macsai, MDAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Aug 15, 2017
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 91 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
In brief, the objective of this study is to investigate whether the drug Glanatec ® which is approved in Japan for glaucoma and ocular hypertension, can be used in patients with Fuchs endothelial dystrophy who have had a descemet stripping procedure without endothelial keratoplasty. While some limited data exists as a proof of concept in in vitro or animal studies, and Glanatec® has been successfully used in a recently published case series for this indication, there is insufficient data to show that this drug can be effectively used for corneal cell clearing while maintaining patient safety. The goal of the study is to provide sufficient proof of concept for the use of this drug in patients with FED whose only treatment alternative is to undergo corneal transplant.
Conditions
- Fuchs' Endothelial Dystrophy
Interventions
Ripasudil hydrochloride hydrate 0.4% ophthalmic solutionDrug
the ophthalmic solution will be administered three or six per times per day in the eye designated as the "Study Eye" upon study enrollment
Primary outcomes
What the sponsor says the trial is designed to measure.
- Corneal ClearingTime frame: 12 months
- pachymetry measurementTime frame: 12 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
NorthShore University HealthSystem
Glenview, Illinois · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.